| dc.contributor.author |
Jadhav, Hemant R. |
|
| dc.date.accessioned |
2023-11-30T10:32:33Z |
|
| dc.date.available |
2023-11-30T10:32:33Z |
|
| dc.date.issued |
2018 |
|
| dc.identifier.uri |
https://benthamscience.com/article/87338 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13288 |
|
| dc.description.abstract |
Novel 4-(3-(4-ethylpiperazin-1-yl)propoxy)-N-phenylbenzamide derivatives (C-1 to C-10) and (4-(3-(4-ethylpiperazin-1-yl)propoxy)phenyl)(4-(2-methoxyphenyl)piperazin-1- yl)ethanone derivatives (C-11 to C-16) were designed and synthesized by pharmacophore approach. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Bentham Science |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Carcinoma |
en_US |
| dc.subject |
Cytotoxocity |
en_US |
| dc.subject |
Epidermal growth factor receptor inhibitors |
en_US |
| dc.subject |
Ethyl piperazine |
en_US |
| dc.subject |
Cancer line |
en_US |
| dc.title |
Design, Synthesis and In Vitro Evaluation of Piperazine Incorporated Novel Anticancer Agents |
en_US |
| dc.type |
Article |
en_US |